Last 47 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
STERIS plc's quarterly P/E stands at 32.3x, up 10.1% year-over-year — indicating the stock has re-rated higher or earnings have softened. EV/EBITDA has expanded 50.9% YoY to 22.9x, reflecting rising market expectations or slowing EBITDA growth.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 34.46 | 32.34 | 31.89 | 33.55 | 38.29 | 29.37 | 40.16 | 37.59 | — | 38.71 | 47.29 | 45.00 | 25.44 |
| — | +10.1% | -20.6% | -10.8% | — | -24.1% | -15.1% | -16.5% | — | +3.9% | — | -4.0% | -78.1% | |
| P/S Ratio | 3.85 | 4.19 | 4.19 | 4.27 | 3.78 | 3.71 | 4.53 | 4.26 | 4.98 | 4.21 | 4.40 | 4.72 | 3.44 |
| — | +12.8% | -7.5% | +0.1% | -24.1% | -11.8% | +2.8% | -9.6% | +44.8% | +10.6% | +27.2% | +5.1% | -31.7% | |
| P/B Ratio | 3.20 | 3.49 | 3.48 | 3.41 | 3.38 | 3.16 | 3.64 | 3.42 | 3.52 | 3.40 | 3.52 | 3.61 | 3.13 |
| — | +10.5% | -4.4% | -0.6% | -3.9% | -6.9% | +3.3% | -5.2% | +12.5% | +11.1% | +23.2% | +11.7% | -16.0% | |
| P/FCF | 27.00 | 31.39 | 30.36 | 18.18 | 29.47 | 20.87 | 40.40 | 27.88 | 34.02 | 31.69 | 86.83 | 26.02 | 32.98 |
| — | +50.4% | -24.8% | -34.8% | -13.4% | -34.1% | -53.5% | +7.2% | +3.1% | -22.0% | -56.0% | -42.0% | -46.6% | |
| EV / EBITDA | 17.15 | 22.87 | 16.80 | 17.46 | 18.03 | 15.16 | 19.62 | 20.21 | 16.73 | 17.13 | 18.35 | 18.80 | 15.02 |
| — | +50.9% | -14.4% | -13.6% | +7.8% | -11.5% | +7.0% | +7.5% | +11.4% | +4.8% | — | -5.4% | -28.3% | |
| EV / EBIT | 26.58 | 22.87 | 24.43 | 25.75 | 28.46 | 22.70 | 30.63 | 29.31 | 25.24 | 27.52 | 32.72 | 31.69 | 24.50 |
| — | +0.7% | -20.3% | -12.1% | +12.8% | -17.5% | -6.4% | -7.5% | +3.1% | -2.3% | — | -15.0% | -66.5% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
STERIS plc's operating margin was 18.1% in Q3 2026, down 0.2 pp QoQ and up 0.2 pp YoY.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 44.0% | 43.8% | 44.2% | 45.1% | 43.3% | 44.5% | 43.6% | 44.7% | 40.2% | 43.2% | 44.1% | 44.7% | 42.5% |
| — | -1.6% | +1.6% | +0.9% | +7.8% | +3.2% | -1.3% | +0.1% | -5.4% | +0.6% | -0.5% | -0.2% | -10.1% | |
| Operating Margin | 15.9% | 18.1% | 18.4% | 17.7% | 14.6% | 17.9% | 16.5% | 14.5% | 22.0% | 17.5% | 15.5% | 16.7% | 16.3% |
| — | +1.2% | +11.0% | +22.0% | -33.5% | +2.6% | +6.8% | -13.2% | +35.0% | +11.2% | +160.6% | +22.0% | +114.5% | |
| Net Margin | 11.3% | 12.9% | 13.1% | 12.8% | 9.8% | 12.7% | 11.3% | 11.4% | -0.1% | 10.8% | 9.3% | 10.4% | 13.5% |
| — | +1.8% | +16.4% | +12.2% | +8073.4% | +16.7% | +21.2% | +8.8% | -100.9% | +6.5% | +135.5% | +8.5% | +213.2% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 9.5% | 2.7% | 2.7% | 2.6% | 2.2% | 2.7% | 2.3% | 2.3% | -0.0% | 2.2% | 1.9% | 2.0% | 3.1% |
| — | +2.1% | +18.7% | +13.9% | +10440.3% | +19.3% | +24.0% | +13.8% | -100.7% | +6.9% | +136.2% | +17.4% | +288.7% | |
| ROA | 5.8% | 1.8% | 1.8% | 1.7% | 1.4% | 1.7% | 1.5% | 1.4% | -0.0% | 1.2% | 1.0% | 1.1% | 1.7% |
| — | +7.1% | +25.0% | +25.7% | +11948.4% | +38.3% | +41.1% | +20.1% | -100.7% | +6.5% | +135.9% | +16.2% | +283.0% | |
| ROIC | 7.2% | 2.6% | 2.3% | 2.1% | 1.9% | 2.1% | 1.9% | 1.5% | 1.9% | 1.8% | 1.5% | 1.6% | 1.9% |
| — | +24.2% | +21.8% | +38.3% | -1.7% | +20.2% | +22.6% | -5.8% | +2.8% | +9.2% | +160.3% | +28.6% | +159.8% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
The current ratio has improved 16.4% YoY to 2.48x, strengthening the short-term liquidity position.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.33 | — | 0.29 | 0.30 | 0.33 | 0.36 | 0.36 | 0.39 | 0.54 | 0.55 | 0.59 | 0.51 | 0.53 |
| — | — | -19.3% | -23.9% | -37.9% | -33.9% | -38.2% | -22.8% | +0.4% | +1.5% | +6.6% | +1.9% | +6.5% | |
| Debt / EBITDA | 1.64 | — | 5.28 | 5.66 | 6.51 | 6.25 | 7.17 | 8.33 | 8.91 | 9.56 | 10.57 | 9.30 | 8.84 |
| — | — | -26.3% | -32.0% | -27.0% | -34.6% | -32.2% | -10.4% | +0.8% | -3.4% | — | -13.1% | -12.3% | |
| Current Ratio | 1.96 | 2.48 | 2.37 | 2.22 | 1.96 | 2.13 | 2.41 | 2.33 | 3.08 | 2.43 | 2.49 | 2.29 | 2.33 |
| — | +16.4% | -1.5% | -4.5% | -36.5% | -12.3% | -3.4% | +1.5% | +32.0% | -2.1% | +15.1% | +12.6% | +14.5% | |
| Quick Ratio | 1.39 | 1.75 | 1.63 | 1.53 | 1.39 | 1.40 | 1.55 | 1.49 | 2.36 | 1.49 | 1.55 | 1.42 | 1.63 |
| — | +24.8% | +5.0% | +2.7% | -41.1% | -6.1% | +0.1% | +4.6% | +44.4% | -7.3% | +8.8% | +5.3% | +15.5% | |
| Interest Coverage | 10.05 | 18.31 | 17.99 | 15.47 | 12.63 | 12.85 | 11.17 | 6.10 | 6.79 | 5.81 | 5.19 | 6.11 | 7.44 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare business quality, growth, and profitability against top sector peers.
Start ComparisonQuick answers to the most common questions about buying STE stock.
STERIS plc's current P/E is 34.5x. The average P/E over the last 4 quarters is 34.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
STERIS plc's current operating margin is 15.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking STERIS plc's business trajectory between earnings reports.